Publication | Closed Access

Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial

Dolutegravir-based Antiretroviral TherapyTreatment And PreventionTuberculosis PreventionPharmacologyAntiviral Drug DevelopmentAntiviral TherapyTuberculosisPharmacotherapyOnce-weekly RifapentineAntiviral DrugHivMedicineDrug Resistance